Insmed Inc’s recent filing unveils that its Director SHAROKY MELVIN MD unloaded Company’s shares for reported $4.1 million on Dec 05 ’25. In the deal valued at $205.01 per share,20,000 shares were sold. As a result of this transaction, SHAROKY MELVIN MD now holds 243,948 shares worth roughly $48.06 million.
Then, MELVIN SHAROKY bought 20,000 shares, generating $4,100,000 in total proceeds.
Before that, Lewis William sold 10,699 shares. Insmed Inc shares valued at $2,199,915 were divested by the Chair and CEO at a price of $205.62 per share. As a result of the transaction, Lewis William now holds 303,911 shares, worth roughly $59.87 million.
Rothschild & Co Redburn initiated its Insmed Inc [INSM] rating to a Buy in a research note published on December 04, 2025; the price target was $263. Wells Fargo began covering INSM with “an Overweight” recommendation on October 20, 2025. William Blair started covering the stock on August 20, 2025. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 0.91% to $197.01. Over the last five days, the stock has lost -3.43%. Insmed Inc shares have risen nearly 171.29% since the year began. Nevertheless, the stocks have risen 185.36% over the past one year. While a 52-week high of $212.75 was reached on 12/02/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 193.12, which if violated will result in even more drops to 189.24. On the upside, there is a resistance level at 199.51. A further resistance level may holdings at 202.02.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-11-28, growing by 1.83 million shares to a total of 9.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 8.03 million shares. There was a rise of 18.58%, which implies that there is a positive sentiment for the stock.
